(Q40203523)

18 September 2017

1 reference

title

Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions (English)

1 reference

18 September 2017

Venditti JM

1

1 reference

18 September 2017

Wesley RA

series ordinal

2

1 reference

18 September 2017

Plowman J

series ordinal

3

1 reference

18 September 2017

language of work or name

1 reference

1 January 1984

1 reference

Advances in pharmacology and chemotherapy

18 September 2017

1 reference

18 September 2017

20

1 reference

18 September 2017

1-20

1 reference

Effects of N-methylformamide and related compounds in mouse sarcoma 180.

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960263-X

7 January 2021

Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960263-X

7 January 2021

The use of drugs in combination for the treatment of cancer: rationale and results

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960263-X

7 January 2021

The National Cancer Chemotherapy Program

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960263-X

7 January 2021

Heterotransplantation of Human Malignant Tumors in “Nude” Thymusless Mice. II. Malignant Tumors Induced by Injection of Cell Cultures Derived From Human Solid Tumors 2

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960263-X

7 January 2021

Development and cross-resistance characteristics of a subline of P388 leukemia resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960263-X

7 January 2021

Transplantation of Human Tumors in Nude Mice23

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960263-X

7 January 2021

Chemical Control of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960263-X

7 January 2021

10.1016/S1054-3589(08)60263-X

Identifiers

DOI

0 references

1 reference